Emerging SARS‐CoV‐2 variants can potentially break set epidemiological barriers in COVID‐19

A Kumar, R Parashar, S Kumar, MA Faiq… - Journal of Medical …, 2022 - Wiley Online Library
Young age, female sex, absence of comorbidities, and prior infection or vaccination are
known epidemiological barriers for contracting the new infection and/or increased disease …

SARS-CoV-2: evolution and emergence of new viral variants

VR Flores-Vega, JV Monroy-Molina… - Viruses, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent
responsible for the coronavirus disease 2019 (COVID-19). The high rate of mutation of this …

SARS-CoV-2 variants: Impact on biological and clinical outcome

S Mahilkar, S Agrawal, S Chaudhary, S Parikh… - Frontiers in …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that was first identified
in December 2019, in Wuhan, China was found to be the etiological agent for a novel …

Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy

S Ramesh, M Govindarajulu, RS Parise, L Neel… - Vaccines, 2021 - mdpi.com
The widespread increase in multiple severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) variants is causing a significant health concern in the United States and …

Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: an insight from structural data

A Khan, T Zia, M Suleman, T Khan… - Journal of cellular …, 2021 - Wiley Online Library
The evolution of the SARS‐CoV‐2 new variants reported to be 70% more contagious than
the earlier one is now spreading fast worldwide. There is an instant need to discover how …

V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding …

J Ou, Z Zhou, R Dai, J Zhang, S Zhao, X Wu… - Journal of …, 2021 - Am Soc Microbiol
The current pandemic of COVID-19 is caused by a novel coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 spike protein receptor …

Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries

R Wang, J Chen, K Gao, GW Wei - Genomics, 2021 - Elsevier
Abstract Recently, the SARS-CoV-2 variants from the United Kingdom (UK), South Africa,
and Brazil have received much attention for their increased infectivity, potentially high …

Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS‐CoV‐2 variants

Q Wang, SB Ye, ZJ Zhou, JY Li, JZ Lv… - Journal of Medical …, 2023 - Wiley Online Library
Increasing evidence supports inter‐species transmission of SARS‐CoV‐2 variants from
humans to domestic or wild animals during the ongoing COVID‐19 pandemic, which is …

Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactions

A Adli, M Rahimi, R Khodaie… - Journal of Medical …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by a highly pathogenic emerging
virus, is called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Knowledge …

SARS-CoV-2 variants of concern and variants of interest receptor binding domain mutations and virus infectivity

H Liu, P Wei, JW Kappler, P Marrack… - Frontiers in …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has lasted
more than 2 years with over 260 million infections and 5 million deaths worldwide as of …